CaPP3 Study opens to recruitment

posted on Monday, 13th October 2014

Not tagged.

[#pageName]

The CaPP3 study opened to recruitment at the Institute of Genetic Medicine, Newcastle on Wednesday 1st October 2014. Professor Sir John Burn consented the first recruit.

The first batch of packed aspirin has been delivered to the pharmacy in Newcastle ready for dispensing.

The study will be recruiting through all the UK Regional Genetics Centres. Over the next few months these centres too will be opening to recruitment, once they have completed their local regulatory processes.

So after several long years of working our way through UK regulatory processes the CaPP3 study is finally open to recruitment.

Nick James was the first to be recruited to the trial in Newcastle.  Read his story at the link below:

Gosforth dad joins clinical trial that could cut risk of Lynch syndrome sufferers getting cancer

ChronicleLive, 7 October 2016

 

Share this!

Latest News

  • 26

    Mar

    2020

    NHS Advice: COVID-19 and aspirin

    posted on Thursday, 26th March 2020
    NHS Advice: COVID-19 and aspirin

    We would like to update you about the NHS advice concerning COVID & aspirin:

    Not tagged.

    Comments (0)

  • 18

    Mar

    2020

    OFFICE CLOSED - COVID-19

    posted on Wednesday, 18th March 2020

    Due to the current COVID-19 situation the CaPP3 Newcastle office is closed until further notice. However, the CaPP3 email address will continue to be monitored - CaPP3@ncl.ac.uk. 

    Not tagged.

    Comments (0)

Downloads